GOTHENBURG, SE / ACCESS Newswire / / AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that CEO Kristina Torfgård will present ...

She had just diagnosed our 11-year-old daughter, Maya, with Nicolaides-Baraitser syndrome, a genetic condition so rare there ...

A University of Cincinnati study links weekly physical activity to slower cognitive decline and motor function loss in Parkinson's disease patients.

Alzinova is at an important stage of development. The global Phase II study of ALZ-101 is in operational start-up together with Worldwide Clinical Trials, with the aim of enrollin ...

Since October 1, Molina has been administering the Florida Children's CMS Plan instead of Sunshine. What happens with ...

Keenova Therapeutics plc announced today that it will share data and insights related to men's health during three speaker ...

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced it will report third quarter 2026 financial results on Tuesday, November 3, 2026, before market open. The ...

GOTHENBURG, SE / ACCESS Newswire / October 9, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that ...

Many people don't know that bone density loss occurs completely silently and without symptoms, until serious problems or ...

New research from the Bogalusa Heart Study has found that greater exposure to clinical obesity during young adulthood is associated with a greater ...

According to neurologist Dr. Baibing Chen, people who want to protect their memory and and cognitive healt usually steer ...